Intensive care unit (ICU)-acquired nosocomial infections (NIs) are thought to increase patient mortality. [1] [2] [3] However, the magnitude of this effect remains controversial and depends on study design, type of infection, and target population. [4] [5] [6] [7] [8] [9] [10] [11] [12] Previous investigations have reported mortality estimates related to ICU-acquired NI of 4%-50%. [1] [2] [3] [4] [5] [6] 9, 10 The corresponding relative risks of death due to ICU-acquired NI were 1.4-4.0, and the corresponding odds ratios were 1.7-3.2. 3, 4, [8] [9] [10] [11] [12] The population-attributable fraction (PAF) of death is a well-known public health concept, defined as "the fraction of patients that would not have died if exposure had not occurred." 13 Various epidemiologic methods can be used to evaluate the PAF, including expert assessment of case series. In contrast to the rich literature available in the field of chronic disease epidemiology, controlled studies aiming to determine the proportion of hospital deaths attributable to NI are both rare and insufficient for the calculation of stable estimates. 14, 15 Furthermore, several methodological issues have to be considered, since the causal relationship between exposure (to a pathogen that causes NI) and death can be jeopardized by multiple confounders and biases, such as severity of the underlying illness and the infection type. 1, 2, 10 In addition, small sample size can be associated with statistical power inadequate to generate meaningful PAF estimates. 16 The objective of this case-control study was to provide accurate estimates of the adjusted PAF of ICU-acquired NI in a large cohort of critically ill patients.
methods

Patients and Setting
Our study was based on data collected prospectively by a nosocomial infection surveillance network 17, 18 during the period from January 1, 1995, through December 31, 2003, from 11 adult ICUs at the University Hospital of Lyon, France.
Design
A case-control study with individual pair matching was undertaken according to the approach proposed by Bruzzi et al. 19 Case patients were patients who died before ICU discharge, whereas control patients were patients who survived to discharge. For each case patient, 1 control patient from the same ICU was selected and matched according to the following criteria: sex, age (stratified into 7 age groups), and year of admission. If multiple control patients were available, the one with the date of admission closest to that of the case patient was retained. The following variables were collected and analyzed as potential confounders: Simplified Acute Physiology Score at ICU admission, immunodepression, and type of condition at admission (medical, surgical, or trauma). 20, 21 All variables were collected according to the criteria of a standardized and validated protocol, established by an ICU surveillance network in France. 17, 18 Definitions of ICU-Acquired NI We defined various risk levels of patient death before discharge from the ICU according to exposures to ICU-acquired NI. Exposure was defined as the presence of at least one ICUacquired NI in a given patient, ascertained according to a standardized protocol and established guidelines. 17, 18, 22, 23 ICUacquired NI was defined as infection that occurred at least 48 hours after admission to the ICU, determined on the basis of clinical and microbiological criteria. 17, 18, 22, 23 The 4 types of ICU-acquired NI considered for analysis were pulmonary infections, central venous catheter (CVC) infections, urinary tract infections (UTIs), and bloodstream infections (BSIs). For each patient, only the first infection in any of these 4 sites was analyzed. We calculated the incidence of ICU-acquired NI as the number of cases of ICU-acquired NI per 100 patients per period (period was the duration of the stay in the hospital).
We stratified analysis by type of infection and number of infected sites. To further explore the complex association between ICU-acquired NI and death in the ICU, we fitted 5 different models, stratified by type of infection and number of infected sites (see Appendix, Table A ). The first model included any type of infection during the ICU stay that occurred in any of the 4 body sites. For this model, only the first ICU-acquired NI for each patient was taken into account. The other 4 subgroup models dealt with each type of ICUacquired NI separately. For each of these models, patients with ICU-acquired NI at only 1 specific, primary site were compared with a patient group without ICU-acquired NI (no infection), with a group who had at least 1 ICU-acquired NI at the primary site with coinfection at 1 or more of the 3 other sites, and finally with a group of patients who had ICUacquired NI at 1 or more of the 3 other sites but no infection at the primary site.
Statistical Analysis
We used the McNemar test to compare proportions and the paired Student t test to compare means. Calculation of the crude PAF of deaths related to ICU-acquired NI was based on the following equation using the relative odds of death (ROD): 
where CF E is the case patient fraction exposed to ICU-acquired NI and is the etiological fraction [(ROD Ϫ 1)/ROD] of attributable risk for case patients to be exposed at least once to ICU-acquired NI.
To perform multivariate analysis and generate an adjusted estimate of the PAF of death due to ICU-acquired NI, we determined the PAF for multiple levels of exposure. An exposure was defined as, for example, the presence in the ICU of 1 patient with 1 pulmonary infection or 1 patient with 1 UTI. Then, to assess the sum of category-specific attributable fractions, we used the following equation:
where CF E1 , CF E2 , and CF E3 are the exposure incidence in case patients according to the different levels of exposure. The quantities ROD 1 , ROD 2 , and ROD 3 are the different RODs according to the levels of exposure and type of ICU-acquired NI (see above). We computed the adjusted RODs and 95% confidence intervals (CIs) with conditional multiple logistic regression models. 28, 29 We incorporated different terms for the specific ICU-acquired NI in the 5 models corresponding to different polytomous "risk levels" of infection (see Appendix, Table  A ). All covariates that reached a statistical threshold (P ! ) in univariate analysis were included in a multivariable .10 model. All analyses were performed with SPSS for Windows, version 10.1 (SPSS).
results
A total of 12,246 patients in 11 ICUs were registered in the surveillance network during the study period. We excluded all patients with incomplete data, leaving 8,068 potentially eligible patients for analysis. The main reason for exclusion was that data were missing for reliable assessment of the presence or absence of ICU-acquired NI. The distribution of missing data was as follows: 24 patients (0.2%) with missing information on possible pulmonary infection, 4,137 patients (33.8%) without information on CVC infection, 56 patients (0.5%) without information on UTI, and 28 patients (0.2%) without information on BSI. In total, data were missing for 4,178 patients (34.1%). ). The range in total incidence among the different P ! .001 ICUs was 6.3%-29.6% ( ). The mean annual inci-P ! .001 dence was 8.0% for pulmonary infection, 7.9% for CVC infection, 7.6% for UTI, and 3.3% for BSI. During the study period, 1,835 patients (22.7%) died before ICU discharge. (Table 2 ). During the P ! .001 study period, the incidence of ICU-acquired NI was 31.0% for case patients and 19.5% for the control patients (P ! ). .001
Attributable Mortality Due to ICU-Acquired NI Table 3 presents crude and adjusted ROD in patients who experienced at least 1 ICU-acquired NI. Each model provides an estimate of the PAF for ICU mortality that relates to ICUacquired NI, stratified by type of infection and the number of infected sites. The PAF for each of the 5 models of ICUacquired NI is reported in Table 4 . The PAF due to ICUacquired NI in patients who died before ICU discharge was 14.6% (95% CI, 14.4%-14.8%), which means that of 100 deaths that occurred before ICU discharge, 14.6 were related to an ICU-acquired NI. Stratified by type of infection, the PAFs were 6.1% (95% CI, 5.7%-6.5%) for pulmonary infection, 3.2% (95% CI, 2.8%-3.5%) for CVC infection, and 1.7% (95% CI, 0.9%-2.5%) for BSI. No significant proportion of deaths was attributable to UTI when it was the patient's only infected site (PAF, 0.0 [95% CI, Ϫ0.4% to 0.4%]). Under the assumption of the additive property of the statistical model used, the sum of all infection-specific PAF values was equal to the global PAF presented in model 1. [25] [26] [27] 
discussion
The objective of this study was to estimate the PAF for patient deaths due to infection acquired before ICU discharge. The 3 major findings of this study were as follows: First, 14.6% of deaths (95% CI, 14.4%-14.8%) might be attributed to ICU-acquired NI. Second, to estimate mortality attributable to ICU-acquired NI, it may be clinically useful and complementary to other, commonly risk-based, methods to use the PAF concept. Third, exposure to ICU-acquired NI was an important determinant of death in our population. The proportion of deaths attributable to ICU-acquired NI was likely associated with the incidence of exposure to infections rather than with the ROD associated with the level of infection. Therefore, the incidence of exposure to infections was far more relevant than only the risk of infection by itself. Because we analyzed attributable risk, in order to find the effect of ICU-acquired NI on mortality, it was more appropriate to study the effect of incidence of infections than to study the effect of risk of infection. For example, the ratio of the ROD of 3.3 for pulmonary infection only (Table 4) to the ROD of 1.4 for at least 1 infected site, pulmonary infection excluded, was 2.4. In contrast, the number of deaths attributable only to PI was 6.1% (95% CI, 5.7%-6.5%) and the number of deaths attributable to at least 1 infected site, PI excluded, was 4.6% (95% CI, 4.3%-4.9%) (Table 4) , so the ratio of deaths attributable only to PI to deaths attributable to at least 1 infected site, PI excluded, was only 1.3. This lower ratio was due to computation of the death attributable proportion, which was taken into account for the incidence of exposure for case patients. The incidence of exposure to only pulmonary infection was 8.7%, compared with 15.9% for at least 1 infected site, pulmonary infection excluded. This finding is an interesting contribution of this study, [30] [31] [32] which underscores the fact that a difference exists between the risk for an event to occur (ie, excess risk) and the attributable risk for the same event, depending on the incidence of exposure to risk factors for that event. In theory, odds is the ratio of the probability that an event of interest occurs to the probability that it does not occur (in contrast, risk is the probability for an event to occur within an exposed population), 33, 34 while an attributable event refers to how many events are the direct consequence of an exposure. 34 This note.
where CF E is the case patient fraction exposed to ICU-acquired
is the etiological fraction of attributable risk for case patients to be exposed at [(ROD Ϫ 1)/ROD] least once to ICU-acquired NI. BSI, bloodstream infection; CVC, central venous catheter; UTI, urinary tract infection.
concept has not been adequately explored in the field of hospital-acquired infections, compared with other public health domains. [35] [36] [37] For clinical practice, these findings could be of major interest. Table 4 reports that 14.6% (95% CI, 14.4%-14.8%) of deaths during ICU stay are attributable to ICU-acquired NI, whatever the site of infection. For pulmonary infection only or pulmonary infection with a coinfection, the proportion of deaths attributable to pulmonary infection was 10.6%. For CVC infection only or CVC infection with a coinfection, the proportion of deaths attributable to CVC infection was 6.1%. Interventions to reduce the mortality attributable to ICU-acquired NI should be focused on these 2 sites of infection because of their high incidence. In particular, because of their incidence and potential effect on mortality, pulmonary infections should be a primary target for interventions. A recent study has demonstrated that prevention of ventilator-associated pneumonia by means of selective digestive tract decontamination and selective oropharyngeal decontamination can reduce ICU and 28-day mortality, compared with no intervention. 38 Additional and less controversial preventive measures to decrease exogenous or endogenous cross-transmission to prevent ventilator-associated pneumonia should be considered. For instance, increased compliance with hand hygiene, short duration of intubation, nonprofound sedation, and correct patient positioning may help to decrease rates of ventilator-associated pneumonia rates and ultimately to decrease the likelihood of death.
For decades, the method chosen for this study has been used in chronic disease epidemiology to examine attributable mortality. Conceptually, we assumed that the ROD was different from the total number of deaths related to an exposure, allowing estimation of the "etiological fraction," as proposed by Samore and Harbarth. 39 The advantage of our method of calculating the PAF is that it takes into account multiple levels of exposure (pulmonary infection, CVC infection, UTI, and BSI). This stems from the PAF concept developed by Levin in 1953: 40 when risk is multilevel (at least 2 categories), confounders are present, and risk adjustment is needed. 26, 27 Some limitations must be addressed. For each patient, only the first infection by site was considered for analysis. Moreover, the cumulative effect of repeated infections was not estimated. The analysis was not stratified by the causative microorganisms responsible for the infection. It was not possible to match or adjust for the causative organisms because infections were frequently polymicrobial. However, a similar study design could be used for patients infected by a specific microorganism of high clinical interest (eg, Staphylococcus aureus or Pseudomonas aeruginosa). In future studies, analysis stratified by microorganism might be helpful to identify the pathogens that are associated with the worst prognosis. [41] [42] [43] Since our estimate of ROD is closer to an odds ratio than to a relative risk, the strength of association could have been overestimated. In addition, the lower incidence of death in the population that was excluded from the analysis because of missing data on ICU-acquired NI ( ) could have N p 4,178 biased our results. In consequence, the true proportion of attributable deaths due to ICU-acquired NI might be lower than in our results. Finally, residual confounding factors cannot be excluded, owing to the design of the surveillance network, since data were collected prospectively for surveillance of ICU-acquired NI and not primarily for survival analysis.
conclusions In summary, the results of this study strongly suggest that an important proportion of ICU deaths was caused by NI. These results support previous evidence that death and ICU-acquired NI are causally linked, but the strength of the association may vary according to the methodological approach taken. The method reported in this study could be considered complex because it has not often been used in the field; however, the use of this method can yield additional results to illuminate a controversial issue. The incidence of exposure was a major determinant identified by use of our method. Therefore, one way to estimate the contribution of ICU-acquired NI to mortality might be based on estimation of the PAF, which takes into account the incidence of exposure to ICU-acquired NI. 
